Takeda: Pipeline, Products, Performance, Potential

Summary

Pharmaceutical company intelligence reports from Espicom provide a full review of the company's activities together with five-year sales forecasts for its key products. The company's financial performance is covered in-depth, from its latest results to a complete analysis of its latest full fiscal year and an outlook for the future. A section on company strategy covers mergers, acquisitions and divestitures, key agreements, products and R&D. An overview of key products and R&D is followed by a comprehensive review of the company's product portfolio and research and development pipeline by therapeutic area. In addition, supplementary appendices provide more in-depth information on financials, agreements and corporate events.

Contents

• Executive Summary
  • Overview
    • Cordis in 2007
      • Recent Key Events
    • Operating Analysis
      • Fig 1: Cordis Sales, 2004-2006 (US$ million)*
      • Latest Results
  • Strategic Focus
• Product Portfolio and R&d
  • Fig 2: Cypher as a Percentage of Total Cordis Sales, Q3 2007
  • Recent Product Approvals
• Cardiology
  • Market Rankings for Interventional Cardiology Products, Q3 2007*
• Drug-Eluting Stents (Des)
• Cypher Sirolimus-Eluting Coronary Stent
• Cypher Select
  • e-SELECT Registry
• Cypher Select plus
• Des and Late Stent Thrombosis
  • Conflicting Evidence
• UK Nice Guidance
• Cypher Clinical Studies
  • New SIRIUS
  • ACROSS-CYPHER
  • Medicare Standard Analytic File Analysis
  • E-SIRIUS
  • Patients with Multi-Vessel Disease
  • DELAYED RRISC Trial
  • SESAMI
  • Cypher v Taxus
• Des Sales and Market Analysis
  • Cypher Revenue, 2006 (US$ million)*
  • Fig 4: Cypher Sales by Region, Q3 2007
  • Fig 5: Global DES Market Shares, Q3 2007*
  • Fig 6: US DES Market Shares*
• Other Cardiology Products
• Regatta Steerable Guidewires
• Percutaneous Transluminal Coronary Angioplasty (Ptca) Dilation Catheters
  • Fire Star and Dura Star Rx PTCA Dilatation Catheters
  • Crescendo
  • over-The-Wire
• Infiniti Diagnostic Catheters
• Emerald Diagnostic Guidewires
• Vista Brite Tip Guiding Catheters
• Steerable Guidewires and Accessories
• Avanti+ Sheath Introducer
• Endovascular Products
  • Market Rankings for Peripheral Products, Q3 2007*
  • Cordis
• Embolic Protection and Carotid Stenting
• Cordis Carotid System
• Precise Pro Rx Nitinol Self-Expanding Stent
• Clinical Trials
• Frontrunner Xp Cto and Outback Ltd
• Peripheral Stents
• Palmaz Balloon-Expandable Stents
• S M A R T Self-Expanding Stents
  • Clinical Studies
• Percutaneous Transluminal Angioplasty (Pta) Balloons
• Guiding Catheters
• Steerable Guidewires and Accessories
• Diagnostic Catheters
• Vena Cava Filters
• Hydrolyser Percutaneous Thrombectomy Catheters
• Neurovascular Disease Management
• Enterprise Vascular Reconstruction Device and Delivery System
• Neurovascular Microcatheters
• Envoy Guiding Catheters
• Steerable Guidewires
• Embolic Products
• Trufill Pushable Coil Vascular Occlusion System
• Trufill Dcs Orbit
• Trufill N-Bca Liquid Embolic System
• Biologics Delivery Systems
• Noga Cardiac Navigation System
• Noga-Star Mapping Catheter
• Biosense Webster Products
• Carto Xp Ep Navigation System
• Cartosound Module
• Cartomerge Image Integration Module
• Ez Steer Bi-Directional Catheters
• Thermocool, Coolflow Pump and Stockert 70 RF Generator
• Navistar Thermocool
• Acuson Acunav
• Ep Diagnostic Catheters
• Research and Development
• Research Establishments
• Research Projects
• next-Generation Stents
• Structural Heart Disease
  • Treatments for Patent Foramen Ovale
• Exoseal Vascular Closure Device
• Microelectronic Technologies
• Treatments for Stroke
• Lower Limb Disease
• Angiogenesis and Cell Therapy
• Research Agreements
• Cardiovascular Biotherapeutics
• Medtronic
• Stereotaxis
  • Cordis
• Philips
• Mesoblast Ltd
• Viacell (Perkinelmer)
• Genvec
• International Activities
  • Revenue by Geographic Location, 2004-2006 (US$ million)
  • Fig 7: Sales by Region, 2006
• The Americas
• USA
• Mexico
• Puerto Rico
• Middle East
• Israel
• Europe
• Belgium
• Ireland
• Italy
• Netherlands
  • Manufacturing Locations
• Appendices
  • Appendix 1 - Key Corporate Events
  • Appendix 2 - Mergers And Acquisitions
    • Key Mergers & Acquisitions
    • Conor Medsystems
    • Ensure Medical
    • LuMend
    • TERAMed
    • Atrionix
    • AngioGuard
    • IsoStent
    • Biosense
    • Nitinol Devices and Components
  • APPENDIX 3 - DIVESTITURES
    • Cordis Neuroscience Business
  • Appendix 4 - Agreements
    • Key Agreements
    • Volcano Corporation
    • Medinol
    • Stereotaxis
    • ClearStream Technologies
    • Siemens Medical Solutions
    • EP MedSystems
    • Brivant
    • Research Foundation of SUNY
    • GE Healthcare
    • Stockert GmbH
    • Wyeth Pharmaceuticals
    • SurModics
  • Appendix 5 - Litigation
    • Boston Scientific
    • Coronary Stent Patents
      • Cordis
      • Promus DES
      • Conor MedSystems (with Angiotech Pharmaceuticals)
    • Detachable Coil Delivery Systems and Pushable Coil Vascular Occlusion Systems
    • Wyeth
    • Medtronic
• Index of Tables
  • Recent Key Events
  • Recent Product Approvals
  • Market Rankings for Interventional Cardiology Products, Q3 2007*
  • Cypher Revenue, 2006 (US$ million)*
  • Market Rankings for Peripheral Products, Q3 2007*
  • Revenue by Geographic Location, 2004-2006 (US$ million)
  • Manufacturing Locations
  • Key Mergers & Acquisitions
  • Key Agreements
• Index of Charts
  • Fig 1: Cordis Sales, 2004-2006 (US$ million)*
  • Fig 2: Cypher as a Percentage of Total Cordis Sales, Q3 2007
  • Fig 4: Cypher Sales by Region, Q3 2007
  • Fig 5: Global DES Market Shares, Q3 2007*
  • Fig 6: US DES Market Shares*
  • Fig 7: Sales by Region, 2006